SHUKRA PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]
SHUKRA PHARMACEUTICALS Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹11 Cr | ₹6 Cr | ₹3 Cr | ₹11 Cr | ₹19 Cr | ₹25 Cr | ₹20 Cr | ₹46 Cr |
Expenses | ₹7 Cr | ₹5 Cr | ₹2 Cr | ₹6 Cr | ₹9 Cr | ₹20 Cr | ₹20 Cr | ₹43 Cr |
Operating Income | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹4 Cr | ₹10 Cr | ₹5 Cr | ₹0 Cr | ₹4 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
Profit Before Tax | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹5 Cr | ₹10 Cr | ₹5 Cr | ₹0 Cr | ₹4 Cr |
Profit After Tax | ₹3 Cr | ₹1 Cr | ₹0 Cr | ₹4 Cr | ₹9 Cr | ₹5 Cr | ₹0 Cr | ₹4 Cr |
EPS | ₹0.72 | ₹0.12 | ₹0.11 | ₹0.91 | ₹8.61 | ₹1.08 | ₹0.15 | ₹2.54 |
Industry Peers & Returns | 1W | 1M | 1Y |
SHUKRA PHARMACEUTICALS | -14.5% | -38.8% | 31.3% |
SUN PHARMACEUTICAL INDUSTRIES | -4.9% | 2.1% | 15.5% |
DIVIS LABORATORIES | -2.2% | 9.3% | 50.5% |
CIPLA | -4.2% | 4.5% | 4.5% |
TORRENT PHARMACEUTICALS | -4.4% | -4.5% | 17.2% |
DR REDDYS LABORATORIES | -1.4% | 4.2% | -8.8% |
MANKIND PHARMA | -0.1% | -1.5% | 6.6% |
ZYDUS LIFESCIENCES | -1.6% | 1.3% | -14.6% |
LUPIN | -2.4% | 3.4% | 19.9% |
SHUKRA PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 90.53 % |
Y-o-Y | -43.97 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹11 Cr | 90.53 | |
Sep2024 | ₹6 Cr | 74.80 | |
Jun2024 | ₹3 Cr | -70.80 | |
Mar2024 | ₹11 Cr | -42.39 | |
Dec2023 | ₹19 Cr | -23.33 | |
Sep2023 | ₹25 Cr | 22.21 | |
Jun2023 | ₹20 Cr | -56.41 | |
Mar2023 | ₹46 Cr | - |
SHUKRA PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 491.29 % |
Y-o-Y | -58.74 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹4 Cr | 491.29 | |
Sep2024 | ₹1 Cr | -17.27 | |
Jun2024 | ₹1 Cr | -81.84 | |
Mar2024 | ₹4 Cr | -53.54 | |
Dec2023 | ₹10 Cr | 87.58 | |
Sep2023 | ₹5 Cr | 1,405.33 | |
Jun2023 | ₹0 Cr | -90.75 | |
Mar2023 | ₹4 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 210.34 % |
Y-o-Y | -26.35 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 37.21% | 210.34 | |
Sep2024 | 11.99% | -52.66 | |
Jun2024 | 25.33% | -37.83 | |
Mar2024 | 40.74% | -19.36 | |
Dec2023 | 50.52% | 144.65 | |
Sep2023 | 20.65% | 1,129.17 | |
Jun2023 | 1.68% | -78.73 | |
Mar2023 | 7.9% | - |
SHUKRA PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 487.20 % |
Y-o-Y | -66.40 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹3 Cr | 487.20 | |
Sep2024 | ₹1 Cr | 10.91 | |
Jun2024 | ₹0 Cr | -87.81 | |
Mar2024 | ₹4 Cr | -57.69 | |
Dec2023 | ₹9 Cr | 100.00 | |
Sep2023 | ₹5 Cr | 1,018.76 | |
Jun2023 | ₹0 Cr | -89.42 | |
Mar2023 | ₹4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 208.25 % |
Y-o-Y | -40.04 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 29.9 % | 208.25 | |
Sep2024 | 9.7 % | -36.56 | |
Jun2024 | 15.29 % | -58.25 | |
Mar2024 | 36.62 % | -26.57 | |
Dec2023 | 49.87 % | 160.83 | |
Sep2023 | 19.12 % | 814.83 | |
Jun2023 | 2.09 % | -75.70 | |
Mar2023 | 8.6 % | - |
SHUKRA PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 500.00 % |
Y-o-Y | -91.64 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0.72 | 500.00 | |
Sep2024 | ₹0.12 | 9.09 | |
Jun2024 | ₹0.11 | -87.91 | |
Mar2024 | ₹0.91 | -89.43 | |
Dec2023 | ₹8.61 | 697.22 | |
Sep2023 | ₹1.08 | 620.00 | |
Jun2023 | ₹0.15 | -94.09 | |
Mar2023 | ₹2.54 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD